Evaluation of in-vitro colistin susceptibility and clinical profile of carbapenem resistant Enterobacteriaceae related invasive infections.

[1]  B. Veeraraghavan,et al.  In-vitro activity of tigecycline and comparator agents against common pathogens: Indian experience. , 2019, Journal of infection in developing countries.

[2]  R. Humphries,et al.  CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests , 2018, Journal of Clinical Microbiology.

[3]  G. Kahlmeter,et al.  Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  H. Ye,et al.  Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae , 2017, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[5]  G. Pankey,et al.  Colistin and Polymyxin B Minimal Inhibitory Concentrations Determined by Etest Found Unreliable for Gram-Negative Bacilli. , 2017, The Ochsner journal.

[6]  Maobai Liu,et al.  Evaluation of automated systems for aminoglycosides and fluoroquinolones susceptibility testing for Carbapenem-resistant Enterobacteriaceae , 2017, Antimicrobial Resistance & Infection Control.

[7]  S. Vasoo.  Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward? , 2017, Journal of Clinical Microbiology.

[8]  Taghreed A. Hafiz,et al.  Emergence of carbapenem-resistant Enterobacteriaceae isolated from patients in a university hospital in Saudi Arabia. Epidemiology, clinical profiles and outcomes , 2017, Journal of Infection and Public Health.

[9]  K. Chew,et al.  Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and mcr-Positive Enterobacteriaceae: Comparison of Sensititre, MicroScan, Vitek 2, and Etest with Broth Microdilution , 2017, Journal of Clinical Microbiology.

[10]  D. S. Kumar,et al.  A Study of 24 Patients with Colistin-Resistant Gram-negative Isolates in a Tertiary Care Hospital in South India , 2017, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[11]  P. Mathur,et al.  First Report on a Cluster of Colistin-Resistant Klebsiella pneumoniae Strains Isolated from a Tertiary Care Center in India: Whole-Genome Shotgun Sequencing , 2017, Genome Announcements.

[12]  S. Mohanty,et al.  In vitro susceptibility of carbapenem-resistant Enterobacteriaceae to colistin: A hope at present , 2016, Indian journal of medical microbiology.

[13]  A. Tsakris,et al.  Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates , 2015, Antimicrobial Agents and Chemotherapy.

[14]  A. Uhlemann,et al.  Population Structure of Klebsiella pneumoniae Causing Bloodstream Infections at a New York City Tertiary Care Hospital: Diversification of Multidrug-Resistant Isolates , 2015, Journal of Clinical Microbiology.

[15]  R. Gopalakrishnan,et al.  Carbapenem resistant Gram-negative bacteremia in an Indian intensive care unit: A review of the clinical profile and treatment outcome of 50 patients , 2014, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[16]  M. Thirunarayan,et al.  Emergence of Pan drug resistance amongst gram negative bacteria! The First case series from India , 2014 .

[17]  M. Chandy,et al.  Colistin-Resistant Klebsiella pneumoniae: Report of a Cluster of 24 Cases from a New Oncology Center in Eastern India , 2014, Infection Control & Hospital Epidemiology.

[18]  M. Falagas,et al.  Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections , 2014, Emerging infectious diseases.

[19]  B. Kalal,et al.  In-vitro susceptibility to colistin and tigecycline in New Delhi metallo-beta-lactamase-1 producing Enterobacteriaceae. , 2013, Indian journal of medical microbiology.

[20]  R. Humphries,et al.  Colistin MIC Variability by Method for Contemporary Clinical Isolates of Multidrug-Resistant Gram-Negative Bacilli , 2013, Journal of Clinical Microbiology.

[21]  R. Bonomo,et al.  Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. , 2013, Diagnostic microbiology and infectious disease.

[22]  Thierry Naas,et al.  Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.

[23]  P. Mathur,et al.  Evaluation of susceptibility testing methods for polymyxin. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[24]  M. Falagas,et al.  Potential of old-generation antibiotics to address current need for new antibiotics , 2008, Expert review of anti-infective therapy.

[25]  J. Andrews,et al.  Determination of minimum inhibitory concentrations. , 2001, The Journal of antimicrobial chemotherapy.

[26]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .